Elsevier joins InChI Trust as a Charter Member
Neuchâtel, Switzerland, 10 September 2009 – Elsevier, a leading publisher of scientific, technical and medical information products and services, today announced it has become one of the Charter Members of the InChI Trust and will have a seat on the board at the first InChI Trust Board meeting on September 11th.
Originally developed by the International Union of Pure and Applied Chemistry (IUPAC), the IUPAC International Chemical Identifier (InChI) is a non-proprietary, international standard to represent chemical structures as an alpha-numeric character string generated by an algorithm. InChIs are machine readable and therefore allow chemistry and chemical structures to be much more navigable and discoverable. The InChI Trust is a not-for-profit organization established to develop and improve on the current InChI standard and thereby further enable the interlinking of chemistry and chemical structures on the web.
Recognizing that scientists need to navigate through a range of information sources, Elsevier has already implemented InChI Keys within Reaxys®, the leading workflow solution for synthetic chemists. The use of InChIs also ties into the broader Elsevier strategy of Content Innovation in which research articles are enriched to provide more depth, value, and context to our users. For the chemistry journals available on ScienceDirect, the incorporation of InChI keys will accordingly improve the discoverability and organisation of compounds within the chemistry scientific literature, facilitating and accelerating connectivity to other research tools and content sources.
“Elsevier understands that chemists use a variety of tools and information sources in their research work,” said Dr. David Evans, Director Scientific Affairs at Elsevier Properties SA, and representing Elsevier at the Trust Board meeting. “The aim is to help them to navigate seamlessly through the relevant data and ultimately help them to increase their research productivity. We believe that InChIs will make an increasing contribution to this ambition and we are therefore delighted to be involved in the InChI Trust from the start.”
“Elsevier is without doubt one of the world’s most important providers of chemistry information.” said InChI Trust Project Director, Dr. Stephen Heller. “They have used InChIs since the outset and we are all delighted to have them as charter members of the InChI Trust as it further reinforces the message that InChIs are set to become a major standard in the communication of chemistry information.”
For more information about Elsevier joining the InChI Trust please contact David Evans, Director Scientific Affairs, Elsevier Properties SA, at email@example.com
About Elsevier Properties SA
Elsevier Properties SA since 2007 has been the owner of the Beilstein Database and the Reaxys trademark. Elsevier Properties SA is a part of Reed Elsevier.
About The InChI Trust
The InChI Trust is a not-for-profit organization to expand and develop the InChI chemical structure representation algorithm. The InChI project was initially undertaken by the International Union of Pure and Applied Chemistry (IUPAC) with the cooperation of National Institute for Standards and Technology (NIST). The IUPAC International Chemical Identifier (InChI) is an alpha-numeric character string generated by an algorithm. The InChI was developed as a new, non-proprietary, international standard to represent chemical structures. In 2009, a standard version of InChI and the InChIKey were released and the InChI Trust was established to support the continued development of InChI, and maintenance of the InChI algorithm.
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Research Intelligence and ClinicalKey— and publishes over 2,500 journals, including The Lancet and Cell, and more than 35,000 book titles, including a number of iconic reference works. Elsevier is part of RELX Group, a world-leading provider of information and analytics for professional and business customers across industries. www.elsevier.com
Elsevier Properties SA